x

NEW UPDATE: Completed trials may now upload and register supplementary documents (e.g. null results reports, populated pre-analysis plans, or post-trial results reports) in the Post Trial section under Reports, Papers, & Other Materials.
Innovation Vouchers
Last registered on October 20, 2017

Pre-Trial

Trial Information
General Information
Title
Innovation Vouchers
RCT ID
AEARCTR-0001556
Initial registration date
August 30, 2016
Last updated
October 20, 2017 7:14 AM EDT
Location(s)
Primary Investigator
Affiliation
Other Primary Investigator(s)
PI Affiliation
PI Affiliation
Additional Trial Information
Status
On going
Start date
2016-04-18
End date
2018-03-31
Secondary IDs
Abstract
Innovate UK started an Innovation Vouchers programme in 2012 to provide support SMEs for their innovation activities. The programme provides SMEs from all sectors financial support of up to £5000 (excluding VAT) for engaging the services of experts from academia, research and technology organisations or the private sector to pursue a certain innovative project within the firm. The programme was conducted in several rounds each year. The evaluation of the programme focuses on the three most recent rounds (Rounds 11-13).

The Innovation Vouchers programme operates as a Randomised Controlled Trial (RCT), which is designed to evaluate causal evidence on the impact and effectiveness of the programme.

In particular, the project team aims to answer the following key questions:
1) Do businesses that are given an Innovation Voucher have more collaboration with external partners than those not given one?
2) Do businesses that are given an Innovation Voucher have more innovation activities than those not given one?
3) Do businesses that are given an Innovation Voucher have a higher innovation output than those not given one?
4) Do businesses that are given an Innovation Voucher have better business performance indicators than those not given one?

Within the analysis, several outcome measures are taken into consideration in order to analyse the impact of the Innovation Vouchers programme.

Hyothesis 1: Innovation vouchers have a positive effect on a firm’s collaboration with external partners.
Primary indicator: Percent of innovation activities conducted with the help of external partners.

Hyothesis 2: Innovation vouchers have a positive effect on a firm’s innovation activities.
Primary indicator: Percent of firm's turnover spent on innovation.

Hyothesis 3: Innovation vouchers have a positive effect on a firm’s innovation output.
Primary indicator: Percent of turnover coming from new or improved products or services.

Hyothesis 4: Innovation vouchers have a positive effect on a firm’s business performance indicators.
Primary indicator: Business turnover.
External Link(s)
Registration Citation
Citation
Heite, Jonas, Laura Huber and Marco Kleine. 2017. "Innovation Vouchers." AEA RCT Registry. October 20. https://doi.org/10.1257/rct.1556-3.0.
Former Citation
Heite, Jonas et al. 2017. "Innovation Vouchers." AEA RCT Registry. October 20. http://www.socialscienceregistry.org/trials/1556/history/22514.
Sponsors & Partners

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information
Experimental Details
Interventions
Intervention(s)
Intervention Start Date
2016-04-18
Intervention End Date
2018-01-31
Primary Outcomes
Primary Outcomes (end points)
Percent of innovation activities conducted with the help of external partners; Percent of firm's turnover spent on innovation; Percent of turnover from new products/services; Business turnover [in £]
Primary Outcomes (explanation)
Secondary Outcomes
Secondary Outcomes (end points)
Secondary Outcomes (explanation)
Experimental Design
Experimental Design
The Innovation Vouchers programme operates as a Randomised Controlled Trial (RCT).
Experimental Design Details
Randomization Method
Randomly allocated by innovation voucher portal
Randomization Unit
Firm
Was the treatment clustered?
No
Experiment Characteristics
Sample size: planned number of clusters
1000 firms
Sample size: planned number of observations
1000 firms
Sample size (or number of clusters) by treatment arms
800 firms treatment, 200 firms control
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Cohen’s d MDES (using 5% significance and 80% power levels, assuming an R-squared explained by co-variates of at least 0.3) is calculated as follows: Broad category (Intent-to-treat: all businesses passing the lottery): 0.23 Narrow category (Treatment: all businesses passing the lottery and passing the eligibility check): 0.32
IRB
INSTITUTIONAL REVIEW BOARDS (IRBs)
IRB Name
IRB Approval Date
IRB Approval Number
Post-Trial
Post Trial Information
Study Withdrawal
Intervention
Is the intervention completed?
No
Is data collection complete?
Data Publication
Data Publication
Is public data available?
No
Program Files
Program Files
Reports, Papers & Other Materials
Relevant Paper(s)
REPORTS & OTHER MATERIALS